|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-5-29
|
|
pubmed:abstractText |
Measurement of exhaled nitric oxide (eNO) is a simple and noninvasive method for assessment of inflammatory airway diseases. eNO is elevated in adolescent patients with perennial allergic rhinitis and related to bronchial hyperresponsiveness. The aim of this study was to investigate whether oral loratadine, montelukast, nasal budesonide or nasal sodium cromoglycate could reduce airway inflammation as indicated by decrease of eNO in children with perennial allergic rhinitis as demonstrated by eNO levels.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetates,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Allergic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Asthmatic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Budesonide,
http://linkedlifedata.com/resource/pubmed/chemical/Cromolyn Sodium,
http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids,
http://linkedlifedata.com/resource/pubmed/chemical/Leukotriene Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Loratadine,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolines,
http://linkedlifedata.com/resource/pubmed/chemical/montelukast
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1328-8067
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
322-7
|
|
pubmed:dateRevised |
2008-5-21
|
|
pubmed:meshHeading |
pubmed-meshheading:17532829-Acetates,
pubmed-meshheading:17532829-Administration, Intranasal,
pubmed-meshheading:17532829-Administration, Oral,
pubmed-meshheading:17532829-Adolescent,
pubmed-meshheading:17532829-Anti-Allergic Agents,
pubmed-meshheading:17532829-Anti-Asthmatic Agents,
pubmed-meshheading:17532829-Breath Tests,
pubmed-meshheading:17532829-Budesonide,
pubmed-meshheading:17532829-Child,
pubmed-meshheading:17532829-Child, Preschool,
pubmed-meshheading:17532829-Cromolyn Sodium,
pubmed-meshheading:17532829-Drug Therapy, Combination,
pubmed-meshheading:17532829-Female,
pubmed-meshheading:17532829-Follow-Up Studies,
pubmed-meshheading:17532829-Glucocorticoids,
pubmed-meshheading:17532829-Humans,
pubmed-meshheading:17532829-Leukotriene Antagonists,
pubmed-meshheading:17532829-Loratadine,
pubmed-meshheading:17532829-Male,
pubmed-meshheading:17532829-Nitric Oxide,
pubmed-meshheading:17532829-Peak Expiratory Flow Rate,
pubmed-meshheading:17532829-Quinolines,
pubmed-meshheading:17532829-Rhinitis, Allergic, Perennial,
pubmed-meshheading:17532829-Single-Blind Method,
pubmed-meshheading:17532829-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
|
|
pubmed:affiliation |
Department of Pediatrics, Faculty of Pediatrics, College of Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan. pedhung@hotmail.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
